永安药业
(002365)
| 流通市值：29.89亿 | | | 总市值：35.86亿 |
| 流通股本：2.46亿 | | | 总股本：2.95亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 948,703,343.51 | 563,704,504.5 | 235,897,297 | 783,167,007.89 |
| 营业总成本 | 804,993,472.61 | 505,141,633.94 | 226,434,212.68 | 791,244,833.8 |
| 其他经营收益 | | | | |
| 营业利润 | 142,729,749.67 | 58,648,816.47 | 10,154,886.84 | 10,649,868.41 |
| 利润总额 | 140,444,443.56 | 57,942,785.9 | 9,158,889.26 | 9,877,889.65 |
| 净利润 | 113,498,117.26 | 42,784,942.19 | 7,988,712.72 | 7,190,064.51 |
| 每股收益 | | | | |
| 其他综合收益 | -307,439.09 | -232,563.76 | -114,894.12 | -170,283.48 |
| 综合收益总额 | 113,190,678.17 | 42,552,378.43 | 7,873,818.6 | 7,019,781.03 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,209,796,703.89 | 1,166,672,004.78 | 1,139,114,984.41 | 1,152,741,751.93 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,091,368,419.46 | 1,061,749,939.32 | 1,056,103,819.69 | 1,047,919,839.17 |
| 资产总计 | 2,301,165,123.35 | 2,228,421,944.1 | 2,195,218,804.1 | 2,200,661,591.1 |
| 流动负债: | | | | |
| 流动负债合计 | 223,719,281.23 | 222,306,381.28 | 191,356,246.61 | 203,935,222.36 |
| 非流动负债: | | | | |
| 非流动负债合计 | 9,019,626.19 | 9,522,795.79 | 13,151,761.56 | 14,786,730.7 |
| 负债合计 | 232,738,907.42 | 231,829,177.07 | 204,508,008.17 | 218,721,953.06 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,074,497,173.28 | 2,002,355,747.59 | 1,995,527,442.99 | 1,987,008,294.36 |
| 股东权益合计 | 2,068,426,215.93 | 1,996,592,767.03 | 1,990,710,795.93 | 1,981,939,638.04 |
| 负债和股东权益合计 | 2,301,165,123.35 | 2,228,421,944.1 | 2,195,218,804.1 | 2,200,661,591.1 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 860,134,065.32 | 507,898,499.68 | 205,587,354.72 | 870,631,819.27 |
| 经营活动现金流出小计 | 777,044,390.22 | 475,808,004.78 | 207,019,130.99 | 731,548,400.33 |
| 经营活动产生的现金流量净额 | 83,089,675.1 | 32,090,494.9 | -1,431,776.27 | 139,083,418.94 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 803,097,432.76 | 515,725,726.47 | 258,297,080.07 | 1,085,407,640.47 |
| 投资活动现金流出小计 | 857,507,063.18 | 544,918,400.29 | 232,730,692.84 | 1,205,457,221.26 |
| 投资活动产生的现金流量净额 | -54,409,630.42 | -29,192,673.82 | 25,566,387.23 | -120,049,580.79 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | 17,500,000 |
| 筹资活动现金流出小计 | 28,820,340.02 | 28,818,288.63 | - | 127,674,916.86 |
| 筹资活动产生的现金流量净额 | -28,820,340.02 | -28,818,288.63 | - | -110,174,916.86 |
| 汇率变动对现金及现金等价物的影响 | -5,375,997.4 | -3,209,054.82 | -1,506,585.83 | 1,321,512.16 |
| 现金及现金等价物净增加额 | -5,516,292.74 | -29,129,522.37 | 22,628,025.13 | -89,819,566.55 |
| 期末现金及现金等价物余额 | 225,069,433.67 | 201,456,204.04 | 253,213,751.54 | 230,585,726.41 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -29,129,522.37 | - | -89,819,566.55 |